ASX - By Stock
|
IMU |
Re:
Looking forward to a 10 cent share price
|
|
supercendol
|
77 |
41K |
12 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
77
|
41K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Looking forward to a 10 cent share price
|
|
supercendol
|
77 |
41K |
2 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
77
|
41K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Looking forward to a 10 cent share price
|
|
supercendol
|
77 |
41K |
7 |
24/12/18 |
24/12/18 |
ASX - By Stock
|
77
|
41K
|
7
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
supercendol
|
1.1K |
650K |
2 |
22/12/18 |
22/12/18 |
Charts
|
1.1K
|
650K
|
2
|
|
Charts
|
CSL |
Re:
CSL Chart
|
|
supercendol
|
1.1K |
650K |
1 |
21/12/18 |
21/12/18 |
Charts
|
1.1K
|
650K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMU Meets Endpoints in Phase 1b Gastric Cancer Trial
|
|
supercendol
|
134 |
86K |
2 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
134
|
86K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Her-Vaxx vs Herceptin vs Cisplatin
|
|
supercendol
|
30 |
11K |
5 |
18/12/18 |
18/12/18 |
ASX - By Stock
|
30
|
11K
|
5
|
|
ASX - By Stock
|
IMU |
Her-Vaxx vs Herceptin vs Cisplatin
|
|
supercendol
|
30 |
11K |
24 |
17/12/18 |
17/12/18 |
ASX - By Stock
|
30
|
11K
|
24
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
8 |
15/12/18 |
15/12/18 |
Charts
|
2.5K
|
1.4M
|
8
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
9 |
14/12/18 |
14/12/18 |
Charts
|
2.5K
|
1.4M
|
9
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
2 |
14/12/18 |
14/12/18 |
Charts
|
2.5K
|
1.4M
|
2
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
1 |
14/12/18 |
14/12/18 |
Charts
|
2.5K
|
1.4M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress
|
|
supercendol
|
66 |
29K |
15 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
66
|
29K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress
|
|
supercendol
|
66 |
29K |
7 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
66
|
29K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress
|
|
supercendol
|
66 |
29K |
2 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
66
|
29K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress
|
|
supercendol
|
66 |
29K |
8 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
66
|
29K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress
|
|
supercendol
|
66 |
29K |
5 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
66
|
29K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Prof Wiedermann - January presentation in SF
|
|
supercendol
|
83 |
36K |
2 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
83
|
36K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Prof Wiedermann - January presentation in SF
|
|
supercendol
|
83 |
36K |
3 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
83
|
36K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Imugene Fake News 22/11/2018
|
|
supercendol
|
8 |
3.9K |
4 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
8
|
3.9K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
13 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
208
|
89K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Imugene Fake News 22/11/2018
|
|
supercendol
|
8 |
3.9K |
10 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
8
|
3.9K
|
10
|
|
ASX - By Stock
|
IMU |
Imugene Fake News 22/11/2018
|
|
supercendol
|
8 |
3.9K |
5 |
22/11/18 |
22/11/18 |
ASX - By Stock
|
8
|
3.9K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
It's going to explode soon
|
|
supercendol
|
19 |
10K |
3 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
19
|
10K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
5 |
21/11/18 |
21/11/18 |
ASX - By Stock
|
208
|
89K
|
5
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
2 |
17/11/18 |
17/11/18 |
Charts
|
2.5K
|
1.4M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
10 |
16/11/18 |
16/11/18 |
ASX - By Stock
|
208
|
89K
|
10
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
1 |
16/11/18 |
16/11/18 |
Charts
|
2.5K
|
1.4M
|
1
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
2 |
16/11/18 |
16/11/18 |
Charts
|
2.5K
|
1.4M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
1 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
208
|
89K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
7 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
208
|
89K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
15 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
208
|
89K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Share Price Should Be 4 Cents
|
|
supercendol
|
15 |
6.5K |
24 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
15
|
6.5K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
11 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
208
|
89K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial
|
|
supercendol
|
208 |
89K |
10 |
13/11/18 |
13/11/18 |
ASX - By Stock
|
208
|
89K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
9 |
09/11/18 |
09/11/18 |
ASX - By Stock
|
58
|
23K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
2 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
58
|
23K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
3 |
08/11/18 |
08/11/18 |
ASX - By Stock
|
58
|
23K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
11 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
58
|
23K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
6 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
58
|
23K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
8 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
58
|
23K
|
8
|
|
ASX - By Stock
|
IMU |
Clinical Trial Website Update
|
|
supercendol
|
58 |
23K |
6 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
58
|
23K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ausbiotech Presentation 30th
|
|
supercendol
|
9 |
4.0K |
3 |
31/10/18 |
31/10/18 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
50 mill dump
|
|
supercendol
|
30 |
12K |
2 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
30
|
12K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
50 mill dump
|
|
supercendol
|
30 |
12K |
1 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
30
|
12K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
50 mill dump
|
|
supercendol
|
30 |
12K |
4 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
30
|
12K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Breaking Into Breast Cancer, Immune Therapy Shows Wider Promise
|
|
supercendol
|
16 |
6.8K |
4 |
25/10/18 |
25/10/18 |
ASX - By Stock
|
16
|
6.8K
|
4
|
|
Charts
|
IMU |
Re:
Charting Only.
|
|
supercendol
|
2.5K |
1.4M |
7 |
19/10/18 |
19/10/18 |
Charts
|
2.5K
|
1.4M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
immunotherapy news article (not IMU)
|
|
supercendol
|
44 |
15K |
4 |
18/10/18 |
18/10/18 |
ASX - By Stock
|
44
|
15K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
immunotherapy news article (not IMU)
|
|
supercendol
|
44 |
15K |
9 |
18/10/18 |
18/10/18 |
ASX - By Stock
|
44
|
15K
|
9
|
|